Fa'amatalaga autu
| Igoa Oloa | Fa'amaumauga | Ituaiga | Talimalo/Puaga | Fa'aoga | Talosaga | Epitope | COA |
| Blocker Antibody | BMGBL01 | Monoclonal | isumu | Fa'ata'ita'iga Pad Togafitiga | LF, IFA, IB, WB | / | La'u mai |
| Blocker Antibody | BMGBL02 | Monoclonal | isumu | Fa'ata'ita'iga Pad Togafitiga | LF, IFA, IB, WB | / | La'u mai |
| Blocker Antibody | BMGBL03 | isumu | isumu | Fa'ata'ita'iga Pad Togafitiga | LF, IFA, IB, WB | / | La'u mai |
| Blocker Antibody | BMGBLP1 | Polyclonal | isumu | Fa'ata'ita'iga Pad Togafitiga | LF, IFA, IB, WB | / | La'u mai |
| Blocker Antibody | BMGBLP2 | Polyclona | Lapiti | Fa'ata'ita'iga Pad Togafitiga | LF, IFA, IB, WB | / | La'u mai |
| Blocker Antibody | BMGBLP3 | Polyclonal | 'oti | Fa'ata'ita'iga Pad Togafitiga | LF, IFA, IB, WB | / | La'u mai |
O le poloka poloka o se sui olaola e faaopoopo i se immunoassay e fusifusia ai antibodies heterophile, ma puipuia lelei le non-analyte-mediated antibody ligation.
O le poloka poloka o se sui olaola e faaopoopo i se immunoassay e fusifusia ai antibodies heterophile, ma puipuia lelei le non-analyte-mediated antibody ligation.E masani ona faʻaaogaina mo enzyme-linked, immunofluorescence ma chemiluminescence.Blockers e mafai ona poloka le faʻalavelave e tupu i le taimi o le suʻega, ma vaevaeina i le pasive blockers ma le active blockers.
